Cookies

Like most websites The Medicine Maker uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.

Drug Discovery

Discovery & Development Drug Discovery

Archived Antivirals

| Angus Stewart

Salicylanilides have been a reliable treatment against tapeworms for much of pharma’s history. Now, they could be used to help fight COVID-19.

Discovery & Development Drug Discovery

Completing the Cell Therapy Revolution

| James Strachan

The question that’s on everyone’s lips: how can developers tackle solid tumors and bring cell therapy to millions?

Manufacture Supply Chain

Moving Beyond Clinical Manufacturing

| Joe Garrity

How to streamline a rapidly expanding field? Joe Garrity of Lonza discusses the pain points and easily missed fixes.

Business & Regulation Small Molecules

The Lilly and the Kumquat

| Angus Stewart

Eli Lilly’s Loxo Oncology has signed a deal with Yi Liu’s Kumquat Biosciences, targeting novel small molecules for immuno-oncology.

Discovery & Development Digital Technologies

Human Proteins: Now Free with No Ads

| Angus Stewart

Google’s DeepMind has opened its AlphaFold protein structure database to the world.

Manufacture Drug Discovery

Bringing Certainty to CAR T-Cell Discovery

| Jim Ross

How can we maximize the potential and production of potentially life-saving therapies?

Discovery & Development COVID-19

Throwing Down the Single-Jab Gauntlet

| Angus Stewart

Crowdsourcing initiative searches for a single-shot MRNA COVID-19 vaccine.

Business & Regulation Analytical Science

AI Reunites Pharma with Mother Nature

| Stephanie Sutton, Angus Stewart

Can AI facilitate a grand comeback for medicines sourced from Mother Nature?

Discovery & Development Digital Technologies

The Revolution Will Not Be Pencil-Sketched

| Angus Stewart

How a new 3D bioprinter could – quite literally – add a new dimension to drug screening and disease modeling.

Discovery & Development Drug Discovery

Unleashing Cellular Potential

| James Strachan

Epigenetic switches are being used to identify the optimal combination of transcription factors required to derive clinically valuable cell types.


Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register